Read-Gene S.A. (WSE:RDG)
Poland flag Poland · Delayed Price · Currency is PLN
4.740
0.00 (0.00%)
At close: Jun 20, 2025, 4:50 PM CET

Read-Gene Revenue

Read-Gene had revenue of 3.76M PLN in the quarter ending March 31, 2025, with 77.63% growth. This brings the company's revenue in the last twelve months to 14.49M, up 34.70% year-over-year. In the year 2024, Read-Gene had annual revenue of 13.23M with 30.38% growth.

Revenue (ttm)
14.49M
Revenue Growth
+34.70%
P/S Ratio
3.86
Revenue / Employee
805.26K
Employees
29
Market Cap
55.88M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202413.23M3.08M30.38%
Dec 31, 202310.15M2.91M40.14%
Dec 31, 20227.24M787.35K12.20%
Dec 31, 20216.45M384.57K6.34%
Dec 31, 20206.07M-296.62K-4.66%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NEUCA 12.82B
Synektik Spólka Akcyjna 592.94M
Voxel 556.98M
Celon Pharma 215.11M
Ryvu Therapeutics 97.57M
Centrum Medyczne ENEL-MED 762.83M
Selvita 359.79M
EMC Instytut Medyczny 836.81M
Revenue Rankings